Related Experiment Video
Updated: May 14, 2026
04:41
Knee Arthrocentesis in Adults
Published on: February 25, 2022
Radionuclide synovectomy in haemophilic joints
Petr Teyssler1, Katarina Kolostova, Vladimir Bobek
1Department of Tumor Biology, 3rd Faculty of Medicine, Charles University, Ruska 87, 100 97 Prague, Czech Republic.
Nuclear Medicine Communications
|February 15, 2013
Summary
Radiation synovectomy (RS) is an effective treatment for chronic haemophilic synovitis, improving outcomes in 75% of patients. This review discusses RS as a primary treatment for haemophilic arthropathy.
Area of Science:
- Orthopedics
- Nuclear Medicine
- Rheumatology
Background:
- Chronic synovitis is a common complication in haemophilia patients.
- Untreated synovitis disrupts chondrocyte metabolism, leading to haemophilic arthropathy.
- Haemophilic arthropathy significantly impacts joint health and patient mobility.
Purpose of the Study:
- To review the efficacy and application of radiation synovectomy (RS) for chronic haemophilic synovitis.
- To provide recommendations for the use of RS as a preferred treatment modality.
- To discuss the aetiopathogenesis, indications, and mechanism of action of RS in haemophilic arthropathy.
Main Methods:
- Review of existing literature on radiation synovectomy for haemophilic synovitis.
- Analysis of the mechanism of action of radioisotopes in treating synovitis.
- Evaluation of clinical outcomes and recommendations for RS application.
Main Results:
- Radiation synovectomy (RS) demonstrates satisfactory results in 75% of haemophiliacs with chronic hypertrophic synovitis.
- RS is a safe, cost-effective, and efficacious therapeutic option.
- The review supports RS as a method of choice for managing haemophilic arthropathy.
Conclusions:
- Radiation synovectomy is a highly effective treatment for chronic haemophilic synovitis.
- Further recommendations on RS utilization can optimize outcomes in haemophilic arthropathy.
- RS offers a valuable therapeutic strategy, including the use of various radioisotopes.
Related Concept Videos
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:20Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
01:07Development of the Limb Synovial Joints
Joints form during embryonic development in conjunction with the formation and growth of the associated bones. The embryonic tissue that gives rise to all bones, cartilage, and connective tissues of the body is called mesenchyme.
The mesenchymal stem cells differentiate into chondrocytes that form the hyaline cartilage, and later the cartilaginous model of the bone. This model further transforms into a bone. This process is known as endochondral ossification.
During development, the limbs...
The mesenchymal stem cells differentiate into chondrocytes that form the hyaline cartilage, and later the cartilaginous model of the bone. This model further transforms into a bone. This process is known as endochondral ossification.
During development, the limbs...
01:16Structural Joints: Synovial Joints
Synovial joints are the most common type of joint in the body. A key structural characteristic for a synovial joint is the presence of a joint cavity. This fluid-filled space is where the articulating surfaces of the bones contact each other. Also, unlike fibrous or cartilaginous joints, the articulating bone surfaces at a synovial joint are not directly connected to each other with fibrous connective tissue or cartilage. This gives the bones of a synovial joint the ability to move smoothly...